CRS: BJMC
Position: Pharmacist of Record
CRS: Whitman-Walker
CRS: JHU
Position: Pharmacist, PharmD, Investigational Drug Pharmacy
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
